Avian polyomavirus is a highly contagious viral disease that affects budgerigars and other psittacine birds, causing particularly severe illness in young birds while adults may carry the virus without showing clinical signs. In budgerigars, this disease was historically known as budgerigar fledgling disease due to its devastating impact on nestlings and recently fledged young. The virus attacks multiple organ systems, including the liver, kidneys, heart, and feather follicles, and can cause sudden death in affected nestlings, often with high mortality rates in affected clutches. Polyomavirus represents one of the most significant infectious disease threats in aviculture and can devastate breeding operations.
The polyomavirus is transmitted through various routes, including direct contact between birds, exposure to contaminated feces and feather dander, and environmental contamination of cages, food, water, and handling equipment. Adult birds that have been infected may become asymptomatic carriers, shedding virus intermittently without showing any clinical signs themselves. This carrier state makes disease control particularly challenging, as apparently healthy birds can introduce the virus into previously unaffected collections. The virus is extremely stable in the environment, remaining infectious for extended periods on contaminated surfaces, which facilitates transmission even without direct bird-to-bird contact.
The impact of polyomavirus on affected birds depends heavily on the age at infection. Young nestlings and fledglings, typically those under six weeks of age, are most severely affected and commonly die acutely, sometimes before showing any clinical signs beyond failure to thrive. Older juvenile birds may develop characteristic feather abnormalities, including dystrophic or missing flight and tail feathers, before potentially succumbing to the disease. Adult budgerigars with intact immune systems are relatively resistant to clinical disease but may become chronic carriers if infected. The devastating losses in young birds, combined with the persistence of infection in survivors, creates significant management challenges.
There is no specific antiviral treatment for avian polyomavirus, and management of affected birds relies on supportive care while the bird's immune system mounts a response. Prevention through biosecurity measures, testing, and vaccination represents the primary approach to controlling this disease. Vaccines are available and have proven effective in reducing disease incidence in breeding operations. For pet bird owners, understanding polyomavirus risk and obtaining birds from tested, negative sources provides the best protection. The prognosis for acutely affected nestlings is poor, but birds that survive acute infection may recover, though they may remain carriers capable of transmitting infection to susceptible birds.
